Results 31 to 40 of about 11,811 (202)
Effect of High-Dose Topical Minoxidil on Erythrocyte Quality in SKH1 Hairless Mice
SKH1 hairless mice are widely used in carcinogenesis and dermatology research due to their bare skin, as exposure to different agents is facilitated. Minoxidil is a cosmetic drug that is recognized as a mitogenic agent, and mitogens are suggested to have
Eduardo Naranjo-Vázquez +6 more
doaj +1 more source
Biology of human hair: Know your hair to control it [PDF]
Hair can be engineered at different levels—its structure and surface—through modification of its constituent molecules, in particular proteins, but also the hair follicle (HF) can be genetically altered, in particular with the advent of siRNA-based ...
A Dugour +173 more
core +1 more source
Infantile generalized hypertrichosis caused by topical minoxidil [PDF]
Rare cases of hypertrichosis have been associated with topically applied minoxidil. We present the first reported case in the Brazilian literature of generalized hypertrichosis affecting a 5-year-old child, following use of minoxidil 5%, 20 drops a day ...
Greice Rampon +3 more
doaj +1 more source
Background: Finasteride acts by reducing dihydrotestosterone levels, thereby inhibiting miniaturization of hair follicles in patients with androgenetic alopecia (AGA).
B S Chandrashekar +4 more
doaj +1 more source
Cantú syndrome with coexisting familial pituitary adenoma [PDF]
Context: Pseudoacromegaly describes conditions with an acromegaly related physical appearance without abnormalities in the growth hormone (GH) axis. Acromegaloid facies, together with hypertrichosis, are typical manifestations of Cantú syndrome.
AD Irvine +23 more
core +2 more sources
Background: The first-line pharmacologic treatment for both male and female pattern hair loss is topical minoxidil. Nonetheless, off-label usage of low-dose oral minoxidil has demonstrated good clinical efficacy and safety.
Bhumika Mahawar +1 more
doaj +1 more source
Minoxidil in trichological practice
Management of patients with alopecia is still a challenging task. Minoxidil is a pyrimidine derivative, a potent KATP channel opener, and has been shown to act as a vasodilating agent.
O. Yu. Olisova, I. P. Gostroverkhova
doaj +1 more source
Background Female pattern hair loss (FPHL) is a distressing common problem. Minoxidil is the only FDA approved medical treatment for FPHL. However, the off-label botanically derived 5-alpha reductase inhibitors (5αRIs) are commonly used despite ...
Fairouz K Badran +2 more
doaj +1 more source
Amine-Functionalized Chitosan/dECM Composite Promotes Cutaneous Regeneration and Hair Follicle Activation by Regulating Oxidative Stress and Inflammation. [PDF]
An amine‐functionalized chitosan and hydrolyzed dECM composite promotes cutaneous regeneration by modulating oxidative stress and inflammatory pathways. The material accelerates wound closure and stimulates hair follicle activation in UV‐damaged cutaneous tissue.
Kim YJ +11 more
europepmc +2 more sources
Pharmacological correction of retinal ischemia/reperfusion by minoxidil [PDF]
Introduction/Objective. The objective of this paper was to increase the effectiveness of pharmacological correction of retinal ischemia-reperfusion by using minoxidil. Methods. The research was carried out on 180 Wistar rats.
Peresypkina Anna A. +4 more
doaj +1 more source

